Retinol-binding protein 4 (RBP4), a potential biomarker of frailty in HIV-infected people on stable antiretroviral therapy.

José-Ramon BlancoL RomeroE Ramalle-GómaraL MetolaV IbarraM SanzJ-A OteoA GarciaL Pérez-Martínez

Published in: HIV medicine (2019)

Differential biomarker expression was present according to Fried status. Longitudinal studies will clarify the utility of these biomarkers as targets for diagnostic or therapeutic intervention.

Keyphrases

hiv infected
antiretroviral therapy
binding protein
human immunodeficiency virus
hiv infected patients
hiv positive
hiv aids
randomized controlled trial
poor prognosis
cross sectional
case control
community dwelling
hepatitis c virus
men who have sex with men